Tricyclazole

Generic Name
Tricyclazole
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C9H7N3S
CAS Number
41814-78-2
Unique Ingredient Identifier
R7U3MEU7VR
Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Phase 2
Not yet recruiting
Conditions
DLBCL
Interventions
Drug: zanubrutinib combined with BEAM
Drug: BEAM
First Posted Date
2024-10-22
Last Posted Date
2024-10-22
Lead Sponsor
Ruijin Hospital
Target Recruit Count
66
Registration Number
NCT06652165

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Not Applicable
Not yet recruiting
Conditions
Autologous Stem Cell Transplantation
Conditioning
Interventions
Drug: modified BEAM
Drug: BEAM
First Posted Date
2023-04-18
Last Posted Date
2023-04-18
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
122
Registration Number
NCT05814718
Locations
🇨🇳

First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

First Posted Date
2014-10-30
Last Posted Date
2021-08-05
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
108
Registration Number
NCT02278796
Locations
🇨🇭

Universitätsspital Zürich, Zürich, Switzerland

🇦🇹

Krankenhaus der Elisabethinen Linz, Linz, Austria

🇦🇹

Hanusch Krankenhaus Wien, Wien, Austria

and more 1 locations

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Phase 3
Active, not recruiting
Conditions
Relapsed Follicular Lymphoma
Interventions
Other: ZEVALIN
Drug: BEAM
First Posted Date
2013-04-09
Last Posted Date
2023-12-14
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Target Recruit Count
159
Registration Number
NCT01827605
Locations
🇮🇹

IRCC Onco-Ematologia, Candiolo, Italy

🇮🇹

Spedali Civili, Brescia, Italy

🇮🇹

Emat Univ - Città della salute e della scienza di Torino, Torino, TO, Italy

and more 35 locations

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

First Posted Date
2011-11-09
Last Posted Date
2021-10-06
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
6
Registration Number
NCT01468311
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

First Posted Date
2007-12-17
Last Posted Date
2023-10-10
Lead Sponsor
University of Nebraska
Target Recruit Count
34
Registration Number
NCT00574509
Locations
🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

First Posted Date
2007-12-12
Last Posted Date
2023-09-07
Lead Sponsor
University of Nebraska
Target Recruit Count
32
Registration Number
NCT00572013
Locations
🇺🇸

University of Nebraska Medical Center, Section of Oncology/Hematology, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy